2022
DOI: 10.1186/s13023-022-02563-8
|View full text |Cite
|
Sign up to set email alerts
|

Fetal umbilical artery thrombosis: prenatal diagnosis, treatment and follow-up

Abstract: Background To analyze the ultrasound imaging and clinical characteristics of fetuses with umbilical artery thrombosis (UAT), explore the potential causes of UAT and construct a prognostic prediction model to guide clinical practice. Methods This was a retrospective cohort study of fetal UAT cases examined at two academic tertiary referral care centers from 2014 to 2020. The basic information of the participants was obtained by interview during fol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 30 publications
(35 reference statements)
0
12
0
Order By: Relevance
“…Therefore, in the expectant management treatment of this patient, an increase in the dose of low molecular weight heparin may be considered to be beneficial in prolonging the gestational age, which needs to be further confirmed in subsequent studies. In the study by Wu et al ( Wu et al, 2022 ), it was found that the expectant management group did not have worse fetal outcomes compared to the urgent treatment group when current screening and therapeutic strategies were implemented ( Li et al, 2019b ), thirty-five pregnant women with thrombosis of umbilical cord were included in these analyses. Sometimes, sudden intrauterine fetal death due to umbilical cord thrombosis is unpredictable.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, in the expectant management treatment of this patient, an increase in the dose of low molecular weight heparin may be considered to be beneficial in prolonging the gestational age, which needs to be further confirmed in subsequent studies. In the study by Wu et al ( Wu et al, 2022 ), it was found that the expectant management group did not have worse fetal outcomes compared to the urgent treatment group when current screening and therapeutic strategies were implemented ( Li et al, 2019b ), thirty-five pregnant women with thrombosis of umbilical cord were included in these analyses. Sometimes, sudden intrauterine fetal death due to umbilical cord thrombosis is unpredictable.…”
Section: Discussionmentioning
confidence: 99%
“…Three key factors are responsible for thrombosis: hypercoagulability, blood ow stasis, and endothelial injury [4]. Using logistic regression, Wu et al recently revealed that maternal gestational diabetes mellitus and fetal umbilical cord abnormalities were also independent risk factors for UAT in their retrospective cohort study [5]. However, the study had major limitations: rst, the data collected were based on retrospective studies and registry data, and second, the generalizability to a broader population with UAT remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…In the study by Wu et al, it was found that the expectant management group did not have worse fetal outcomes compared to the urgent treatment group when current screening and therapeutic strategies were implemented [5]. Therefore, fetal protection should be considered for fetuses with very low gestational age, whereas urgent delivery is preferred for fetuses with higher gestational age to avert unnecessary fetal loss.…”
Section: Discussionmentioning
confidence: 99%
“…Maternal diabetes has been reported as a non-genetic risk factor of DAA as well as umbilical artery thrombosis. 17 Although the effect size of MTHFR variants (C677T, A1298C) is weak, a recent integrative study demonstrated the significant risk of heterozygous MTHFR C677T (odds ratio: 1.33). 18 We did not conduct a genetic study for MTHFR variants in the present patient because (1) approximately half of healthy Japanese individuals have an allele of MTHFR C677T (AV genotype), and (2) the VV but not the AV genotype is a significant risk factor for adult Japanese patients with deep vein thrombosis.…”
Section: Accepted Manuscriptmentioning
confidence: 99%